SBIR/STTR Research Award

A Machine Learning Software Tool for Automatic Segmentation and Analysis of T1p MR Images of Knee Cartilage for OA Diagnosis and Treatment Monitoring

Award identifier db989d6b69bda3f095493f7c36dd2ff397663aa7b89094783182a59da98c5600Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$313,358

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CadnzaMed LLC
Proposal award date
2025-08-01
Contract end date
2026-03-31
UEI
KY4YSEPMCDZ1
Solicitation number
PA24-245
Topic code
NIAMS

Research abstract

Abstract Osteoarthritis (OA) is a debilitating disease that results in cartilage loss and pain, generating a significant impact on morbidity and healthcare costs worldwide. No drug is currently available for OA. Many therapeutic targets are being pursued by pharmaceutical companies to develop successful disease modifying therapy for OA. However, the major impediment in the development of effective OA therapeutics is the absence of an imaging biomarker, sensitive to soft tissue changes, that can be reliably used as a quantitative measure of OA disease progression, as well as of responses to therapy, for measuring disease modifying effects of drug candidates in clinical trials. 3D T1r MRI has been shown to be sensitive in detecting early cartilage abnormalities in OA patients including the finding that there is an elevation in T1ρ values in early, moderate and advanced stages of OA, when compared with corresponding asymptomatic subjects. Therefore, T1r biomarker has a tremendous potential to be used a primary quantitative endpoint for efficacy in OA clinical trials. However, there are two critical issues for implementing the use of T1r biomarker in OA clinical trials that necessitates measurements of its variability across MRI scanners and development of a software tool for automated segmentation of cartilage images and generation of the corresponding T1r values. We have already addressed the first issue by establishing T1ρ values of healthy subjects across MRI scanners with a maximum reproducibility error of less than 10% at a 95% confidence level, a major first step for an imaging method to be used in clinical trials. We will address the 2nd issue in this proposal where we will develop a deep network and multi-atlas label fusion framework for automatic segmentation of knee cartilage from previously collected T1ρ MR images of 25 healthy volunteers (N=300 data sets). We will then calculate the cartilage mean T1ρ values from all the automatically segmented images and compare these with T1ρ values obtained by manual segmentation in each data set. At the end of this study, we will develop a software tool combining the automated cartilage segmentation method and our algorithm to generate the T1r values for automatic segmentation and analysis of T1r MR images of knee cartilage - enabling patient stratification and monitoring the response to treatment in OA clinical trials to develop disease modifying drugs.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2020–2025). Reported award amounts total $935,836. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.